|Bid||0.7900 x 0|
|Ask||0.8000 x 0|
|Day's Range||0.7750 - 0.8300|
|52 Week Range||0.5900 - 2.1500|
|Beta (5Y Monthly)||3.02|
|PE Ratio (TTM)||N/A|
|Earnings Date||Sept 18, 2023 - Sept 22, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.97|
Aurora Cannabis (NASDAQ: ACB) might seem like another humdrum marijuana stock, but there are actually a few nuances and recent developments that mean that there's a bit more than meets the eye. This will equip you to make the best investment decision regarding Aurora Cannabis. Aurora's home market is in Canada, where it sells medicinal marijuana.
Stocks in the cannabis sector have been bid up in recent weeks thanks to some political news surrounding marijuana's legal status in the United States. Aurora Cannabis (NASDAQ: ACB) has been one of them with a 50% gain over the last month. Today, however, Aurora stock is getting hit hard.
EDMONTON — Shares of Aurora Cannabis Inc. were down more than 10 per cent after the cannabis company announced plans to raise $33.8 million in a share offering. The company says Canaccord Genuity has agreed to buy, on a bought deal basis, 46,250,000 shares of the company at a price of 73 cents per share. It has also granted Canaccord Genuity an over-allotment option for up to an additional 6,937,500 shares on the same terms. If the over-allotment option is exercised in full, the offering will to